PL3710025T3 - Biomasa sinic do zastosowania w leczeniu zakażenia wirusem zapalenia wątroby typu b - Google Patents
Biomasa sinic do zastosowania w leczeniu zakażenia wirusem zapalenia wątroby typu bInfo
- Publication number
- PL3710025T3 PL3710025T3 PL18877323.8T PL18877323T PL3710025T3 PL 3710025 T3 PL3710025 T3 PL 3710025T3 PL 18877323 T PL18877323 T PL 18877323T PL 3710025 T3 PL3710025 T3 PL 3710025T3
- Authority
- PL
- Poland
- Prior art keywords
- cyanobeacya
- hepatitis
- biomass
- treatment
- virus infection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762587488P | 2017-11-17 | 2017-11-17 | |
| PCT/US2018/061613 WO2019099897A1 (en) | 2017-11-17 | 2018-11-16 | Use of cyanobacterial biomass in treating hepatitis b virus infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3710025T3 true PL3710025T3 (pl) | 2025-02-10 |
Family
ID=66538857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18877323.8T PL3710025T3 (pl) | 2017-11-17 | 2018-11-16 | Biomasa sinic do zastosowania w leczeniu zakażenia wirusem zapalenia wątroby typu b |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12251409B2 (pl) |
| EP (1) | EP3710025B1 (pl) |
| JP (1) | JP7616884B2 (pl) |
| KR (1) | KR102652201B1 (pl) |
| CN (1) | CN111356465A (pl) |
| AU (2) | AU2018368465A1 (pl) |
| PL (1) | PL3710025T3 (pl) |
| SG (1) | SG11202004394PA (pl) |
| TW (1) | TW201932132A (pl) |
| WO (1) | WO2019099897A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI763916B (zh) * | 2017-08-30 | 2022-05-11 | 遠東生物科技股份有限公司 | 藍綠藻萃取物及其製備方法與用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006078284A2 (en) | 2004-05-04 | 2006-07-27 | University Of South Carolina | Methods and compositions related to antiviral therapy using algae and cyanobacteria |
| US20050281839A1 (en) * | 2004-06-18 | 2005-12-22 | Amha Belay | Spirulina composition and antiallergic food |
| DE102006029448A1 (de) * | 2006-06-21 | 2007-12-27 | Christian Dr. Ing. Walter | Pharmazeutische Zusammensetzung mit einem extrazellulären Polyanion aus Arthrospira |
| CN101869585B (zh) * | 2009-04-24 | 2012-08-08 | 远东生物科技股份有限公司 | 用于辅助b型肝炎药物治疗效果的组合物 |
| TWI542354B (zh) * | 2010-11-17 | 2016-07-21 | 遠東生物科技股份有限公司 | 可抑制流感病毒血球凝集素(Hemagglutinin)的醫藥組合物及其製備方法 |
-
2018
- 2018-11-16 PL PL18877323.8T patent/PL3710025T3/pl unknown
- 2018-11-16 JP JP2020526871A patent/JP7616884B2/ja active Active
- 2018-11-16 KR KR1020207014856A patent/KR102652201B1/ko active Active
- 2018-11-16 EP EP18877323.8A patent/EP3710025B1/en active Active
- 2018-11-16 SG SG11202004394PA patent/SG11202004394PA/en unknown
- 2018-11-16 TW TW107140848A patent/TW201932132A/zh unknown
- 2018-11-16 AU AU2018368465A patent/AU2018368465A1/en not_active Abandoned
- 2018-11-16 CN CN201880073742.3A patent/CN111356465A/zh active Pending
- 2018-11-16 WO PCT/US2018/061613 patent/WO2019099897A1/en not_active Ceased
-
2020
- 2020-05-15 US US16/875,474 patent/US12251409B2/en active Active
-
2022
- 2022-05-27 AU AU2022203621A patent/AU2022203621B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022203621A1 (en) | 2022-06-16 |
| US20200276251A1 (en) | 2020-09-03 |
| AU2022203621B2 (en) | 2025-06-05 |
| EP3710025A4 (en) | 2021-05-26 |
| TW201932132A (zh) | 2019-08-16 |
| KR102652201B1 (ko) | 2024-03-27 |
| SG11202004394PA (en) | 2020-06-29 |
| JP7616884B2 (ja) | 2025-01-17 |
| CN111356465A (zh) | 2020-06-30 |
| WO2019099897A1 (en) | 2019-05-23 |
| US12251409B2 (en) | 2025-03-18 |
| EP3710025B1 (en) | 2024-09-18 |
| AU2018368465A1 (en) | 2020-05-28 |
| EP3710025A1 (en) | 2020-09-23 |
| KR20200079276A (ko) | 2020-07-02 |
| JP2021503460A (ja) | 2021-02-12 |
| EP3710025C0 (en) | 2024-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT3684377T (lt) | Hepatito b infekcijos gydymo būdai | |
| IL280459A (en) | Phosphoramidates for the treatment of hepatitis b virus | |
| HRP20190352T1 (hr) | Novi 6-kondenzirani heteroarildihidropirimidini za liječenje i profilaksu infekcije virusom hepatitisa b | |
| IL257384A (en) | Preparations containing rnai and their use for the treatment of infection with the hepatitis b virus | |
| DK3043865T3 (da) | Fremgangsmåder og farmaceutiske sammensætningr til behandlingen af hepatitis b-virusinfektion | |
| IL245436A0 (en) | New dihydroquinolizinones for the treatment and prevention of hepatitis b virus infection | |
| ZA201507840B (en) | 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection | |
| MX383929B (es) | Derivados y métodos de tratamiento de las infecciones por hepatitis b. | |
| HRP20180639T1 (hr) | Derivati izoindolina, namijenjeni upotrebi u liječenju virusne infekcije | |
| DK3137078T3 (da) | Behandling af hepatitis delta-virusinfektion | |
| IL249660A0 (en) | Methods for treating hepatitis b virus and hepatitis d virus infections | |
| SI3204030T1 (sl) | Kombinirano zdravljenje okužbe s HBV in HDV | |
| DK3370723T3 (da) | Behandling af hepatitis delta-virusinfektion | |
| IL246643B (en) | Compositions and kits for treating human immunodeficiency virus/accquired immunodeficiency syndrome | |
| PL3710025T3 (pl) | Biomasa sinic do zastosowania w leczeniu zakażenia wirusem zapalenia wątroby typu b | |
| TH1601001266A (th) | วิธีการและองค์ประกอบทางเภสัชกรรมสำหรับการบำบัดการติดเชื้อไวรัสตับอักเสบ b | |
| ZA201604784B (en) | Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection |